HomeProceduresLiver Transplant

Liver Transplant

Major abdominal operation that removes a diseased liver and replaces it with a deceased- or living-donor graft, indicated for end-stage liver disease and acute liver failure.

Surgical Right upper abdomen (orthotopic liver position) Avg. stay 30 days 0 clinics

Overview

Liver transplantation is the definitive treatment for end-stage chronic liver disease (notably cirrhosis from viral hepatitis, alcohol-related liver disease and non-alcoholic steatohepatitis), acute liver failure, selected hepatocellular carcinoma (within Milan criteria), inherited metabolic liver disorders and certain biliary diseases such as primary sclerosing cholangitis. Grafts may be whole organs from deceased donors or partial (right or left lobe) grafts from living donors. NHS Blood and Transplant describes the operation as major surgery taking 5-8 hours, performed through an upper-abdominal incision shaped like a hockey stick or upside-down Y. The diseased liver is mobilised and removed; the donor liver is then implanted with anastomoses of the suprahepatic and infrahepatic inferior vena cava, the portal vein, the hepatic artery and finally the bile duct. Coagulation is monitored intensively throughout, and a veno-venous bypass or temporary porto-caval shunt may be used to maintain venous return. Intensive-care monitoring follows for 1-3 days and the typical hospital stay is 2-4 weeks. International patients undertaking transplant abroad usually need to remain in-country for at least 4-8 weeks, both for monitoring of immediate graft function and for early immunosuppression management. Lifelong immunosuppression is required to prevent rejection, and one-year graft survival in established centres exceeds 90 percent. Sources: NHS Blood and Transplant, NICE, NIH/PMC transplant literature.

Hospital & stay

2–3 nights
Hospital stay
30 days
Total stay abroad
Surgical
Procedure type

Procedure details

How it's performed

Under general anaesthesia and via an upper-abdominal hockey-stick or inverted-Y incision, the surgical team mobilises the cirrhotic liver, divides ligamentous attachments, and clamps the vena cava and portal vein before hepatectomy. The donor liver is then implanted with end-to-end anastomoses of the suprahepatic and infrahepatic IVC, the portal vein and the hepatic artery, with reperfusion in stages. Bile drainage is restored by direct duct-to-duct anastomosis or Roux-en-Y choledochojejunostomy. Drains are placed and the abdomen is closed.

Preparation
  1. 1Comprehensive transplant assessment: MELD/UKELD scoring, cardiac and pulmonary work-up, dental review, infection screen.
  2. 2Listing on the national transplant registry with regular re-evaluation; or living-donor work-up if relevant.
  3. 3Optimise nutrition (high-protein, branched-chain amino acids) and manage ascites, encephalopathy and varices.
  4. 4Vaccinations (hepatitis B, pneumococcus, influenza) before transplantation.
  5. 5Pre-operative bloods and cross-match; psychological preparation for lifelong immunosuppression.
Recovery
  1. 1Day 0-3: Intensive care monitoring, ventilator support, daily Doppler ultrasound of vascular anastomoses.
  2. 2Days 3-14: Step-down ward; initiation and titration of tacrolimus-based immunosuppression; physiotherapy.
  3. 3Weeks 2-4: Hospital discharge once graft function is stable, drains removed and patient self-caring.
  4. 4Weeks 4-12: Frequent outpatient blood tests, immunosuppression dosing, surveillance for rejection and infection.
  5. 5Months 3-6: Gradual return to office work; close monitoring of liver enzymes, drug levels and CMV.
  6. 6Lifelong: Annual review, cancer surveillance and lifelong immunosuppression.

Related procedures

Related procedures

Liver Transplantation: Outcomes, Donor Options and the Supporting Evidence

14 peer-reviewed sources

Liver transplantation is the definitive treatment for end-stage liver disease and for selected liver cancers, and its outcomes are documented in large cohorts, registry analyses, meta-analyses and international guidance. Contemporary data show that transplantation is the major determinant of long-term survival in patients who would otherwise face progressive liver failure, with many recipients living well beyond ten years. Comparative studies of living-donor and deceased-donor transplantation report broadly comparable, and in some settings superior, recipient survival with living donation, alongside careful attention to donor safety. For hepatocellular carcinoma, transplant selection criteria continue to evolve beyond the original Milan thresholds, and network meta-analyses are refining how expanded criteria balance access against recurrence risk. The references below draw on outcome cohorts, comparative meta-analyses, standardized donor-evaluation protocols and selection-criteria research relevant to patients considering transplantation.

  1. Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma
    Rezaee-Zavareh MS et al. · Hepatology communications · 2026
    Clinical studyPMID 42043868DOI
  2. Meta-Analysis: Comparison of Living Versus Deceased Liver Transplantation for Primary Sclerosing Cholangitis
    Afonso AB et al. · Alimentary pharmacology & therapeutics · 2025
    Systematic review / meta-analysisPMID 40890931DOI
  3. Comparative Outcomes of Living and Deceased Donor Liver Transplantation in Adults: A Systematic Review and Meta-Analysis
    Rashid B et al. · Journal of clinical medicine · 2025
    Systematic review / meta-analysisPMID 41517491DOI
  4. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review
    Yang Y et al. · Journal of clinical medicine · 2025
    Narrative reviewPMID 40364079DOI
  5. Liver Transplantation Versus Resection for Hepatocellular Carcinoma: An Umbrella and Meta-Meta-Analysis of Published Evidence, 2000-2025
    Kim SH et al. · Cancers · 2025
    Systematic review / meta-analysisPMID 41514524DOI

Compiled from peer-reviewed medical literature indexed on PubMed. This overview is for general education and is not medical advice. · Last updated 2026-06-15